(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WZZLD89');

window.addEventListener('pushdatalayer', function(event) { const section = event.detail?.siteSection; const subsection = event.detail?.siteSubsection; const pageUrl = event.detail?.pageUrl; const pageTitle = event.detail?.pageTitle; const promptSelection = event.detail?.promptSelection; const formId = event.detail?.formId; const dataLayerEvent = { event: event.detail.eventName, eventCallback: function () { document.dispatchEvent(new CustomEvent('postdatalayerpush', { bubbles: true, composed: true, detail: event.detail, })); }, }; if (section) { dataLayerEvent['site_section'] = section; } if (subsection) { dataLayerEvent['site_subsection'] = subsection; } if (pageUrl) { dataLayerEvent['pageUrl'] = pageUrl; } if (pageTitle) { dataLayerEvent['pageTitle'] = pageTitle; } if(promptSelection){ dataLayerEvent['promptSelection'] = promptSelection; } if(formId){ dataLayerEvent['form_ID'] = formId; } window.dataLayer = window.dataLayer || []; window.dataLayer.push(dataLayerEvent); });

document.addEventListener('checkcookie', () => { var hasCookie = document.cookie.split(';') .some((cookie) => cookie.trim().startsWith('CookieConsent=')); document.dispatchEvent(new CustomEvent('hascookie', { detail: hasCookie })); });

Skip to Content

Privacy Policy.

" c-nmssatomrichtext_nmssatomrichtext-host="">

We use cookies to keep our site safe and provide an enhanced, personalized experience. You can choose to accept or manage optional cookies. More details about how we protect and use your information can be found in our Privacy Policy.

Get MS Support
Accessibility
Sign In

Main Menu

Understanding MS
Understanding MS
Understanding MS Overview
- What Is MS?
- Newly Diagnosed
  - Newly Diagnosed Overview
  - Understanding Your Diagnosis
- MS Research
  - MS Research Overview
  - Pathways to Cures
Managing MS
Managing MS
Managing MS Overview
- Treating MS
- Living With MS
- For Carepartners
  - For Carepartners Overview
  - Caring for Someone With MS
Resources
Resources
Resources Overview
- Get Support
- Get Connected
- Financial Planning
How You Can Help
How You Can Help
How You Can Help Overview
- Get Involved
- Ways To Give
- Corporate Partners
For Professionals
For Professionals
For Professionals Overview
- For Healthcare Professionals
- For Researchers
About the Society
About the Society
- Who We Are
- Careers at the Society
  - Careers at the Society Main Page
- Newsroom
  - Newsroom Main Page
News and Magazine
News and Magazine
- News
  - News Feed
- Momentum Magazine

Breadcrumb Navigation

Home
Managing MS
Treating MS
Disease-Modifying Therapies
Patient Assistance Programs

Patient Assistance Programs

Financial Assistance Programs for Disease-Modifying Therapies (DMTs)

Prescription Assistance page." c-nmssatomrichtext_nmssatomrichtext-host="">

If you are currently taking a disease-modifying therapy (DMT) or considering one, use the links below to review available patient assistance programs. These programs help offset the cost of DMTs if you qualify. If you are enrolled in a specific program, please reference these sites periodically to make sure you have the most current information.In addition to pharmaceutical manufacturer assistance programs for DMTs, there is financial assistance available from other trusted sources. Please see below for these additional resources, which assist with medication and infusion costs.For help deciding which programs fit your needs, or to find additional resources, see our Prescription Assistance page.

Prescription Assistance page." c-nmssatomrichtext_nmssatomrichtext-host="">

If you are currently taking a disease-modifying therapy (DMT) or considering one, use the links below to review available patient assistance programs. These programs help offset the cost of DMTs if you qualify. If you are enrolled in a specific program, please reference these sites periodically to make sure you have the most current information.In addition to pharmaceutical manufacturer assistance programs for DMTs, there is financial assistance available from other trusted sources. Please see below for these additional resources, which assist with medication and infusion costs.For help deciding which programs fit your needs, or to find additional resources, see our Prescription Assistance page.

Pharmaceutical Manufacturer Assistance

Avonex® (a-vuh-necks)
Bafiertam® (bah-feer-tam)
Betaseron® (bay-ta-seer-on)
Briumvi™ (bree-um’-vee)
Copaxone® (co-PAX-own)
Glatiramer acetate injection (generic equivalent of Copaxone 20mg & 40mg doses)
Glatopa®
Kesimpta® (kes·imp·ta)
Lemtrada® (lem-TRA-da)
Mavenclad® (MAY-ven-klad)
Mayzent® (Māʹzĕnt)
Ocrevus Zunovo™ (OH-creh-vus zoo-NOH-voh)
Ocrevus® (oak-rev-us)
Plegridy® (PLEGG-rih-dee)
Ponvory™ (pon-VOR-ee)
Rebif®
Tascenso ODT® (tuh-SEN-soh ODT)
Tecfidera® (teck-fi-DARE-ah)
Tysabri® (tie-SA-bree)
Vumerity® (vue mer' i tee)
Zeposia® (zeh-poe’-see-ah)

The following DMTs do not offer patient assistance programs at this time.

The following DMTs do not offer patient assistance programs at this time.

Aubagio® (oh-BAH-gee-oh)
Dimethyl Fumarate
Extavia® (ex tā vee uh)
Gilenya® (je-LEN-yah)
Novantrone® (U.S. and Canada)
Tyruko® (tie-ROO-koh) (natalizuman-sztn, biosimilar to Tysabri)

Infusion Center Resources

online Infusion Center Finder. This tool helps you locate centers throughout the U.S. that administer IV/injectable medications. You can also find our co-branded Multiple Sclerosis Infusion Guide on the IAF website." c-nmssatomrichtext_nmssatomrichtext-host="">

Infusion Access Foundation (IAF): Non-profit patient advocacy organization that offers an online Infusion Center Finder. This tool helps you locate centers throughout the U.S. that administer IV/injectable medications. You can also find our co-branded Multiple Sclerosis Infusion Guide on the IAF website.

Follow Us on Social:

Quick Links

Donate Now
Ways To Give
Fundraising Events
Get Involved
Legal Notice and Privacy Policy
Contact Us
Cookie Preferences

By using this website, you agree to our Terms of Use (last updated August 2025).

© 2025 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.

The National Multiple Sclerosis Society is proud to be a source of information on multiple sclerosis related topics. Unless otherwise indicated, the information provided is based on professional advice, published experience and expert opinion. However, the information does not constitute medical or legal advice. For specific medical advice, consult a qualified physician. For specific legal advice, consult a qualified attorney.

Patient Assistance Programs